Major trial aims to tame transplant bleeding without causing clots
NCT ID NCT07157631
Summary
This large study is testing if a drug called tranexamic acid (TXA) can safely reduce dangerous blood loss during liver transplant surgery. Over 1500 adult patients receiving a transplant will be randomly given either TXA or a placebo (saltwater) during their operation. The main goals are to see if TXA reduces bleeding more than the placebo and, crucially, that it does not cause more blood clots in the week after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANEXAMIC ACID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anesthesiology, Renji Hospital, Shanghai Jiao Tong university school of medicine.
RECRUITINGShanghai, Shanghai Municipality, 200123, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.